Last updated on August 2018

A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC)

Brief description of study

This randomized, multi-center, active-controlled, open-label, parallel-group study will investigate the efficacy and safety of biomarker-driven maintenance treatment for first-line mCRC. Participants with mCRC are eligible for entry and cannot have received any prior chemotherapy in the metastatic setting. The entire study duration is anticipated to be approximately 7.5 years.

Clinical Study Identifier: NCT02291289

Contact Investigators or Research Sites near you

Start Over

Cl nica Viedma

Viedma, Rio Negro, Argentina

Institut Jules Bordet X

Brussels, Belgium

UZ Leuven Gasthuisberg

Leuven, Belgium

AZ Delta (Campus Wilgenstraat)

Roeselare, Belgium

University Clinical Center of the Republic of Srpska

Banja Luka, Bosnia and Herzegovina

Clinicas Oncologicas Integradas - COI

Rio De Janeiro, Brazil

Hospital das Clinicas - UFRGS

Porto Alegre, Brazil

Hospital Sao Lucas - PUCRS

Porto Alegre, Brazil

Hospital de Base de Sao Jose do Rio Preto

Sao Jose do Rio Preto, Brazil

Clinique Sainte Catherine

Avignon, France

Hopital Haut Leveque

Pessac, France

Br derkrankenhaus St. Josef

Paderborn, Germany

Prosper-Hospital, Medizinische Klinik I

Recklinghausen, Germany

Praxis F r Haematologie & Onkologie

Saarbruecken, Germany

Thermi Clinic; Oncology Clinic

Thermi Thessalonikis, Greece

Bioclinic Thessaloniki

Thessaloniki, Greece

Seoul National University Hospital

Seoul, Korea, Republic of

Asan Medical Center

Seoul, Korea, Republic of

Samsung Medical Center

Seoul, Korea, Republic of

Cancerologia de Queretaro; Oncologia

Queretaro, Queretaro, Mexico

Antoni van Leeuwenhoek Ziekenhuis

Amsterdam, Netherlands

Ijsselland Ziekenhuis; Inwendige Geneeskunde

Capelle a/d IJssel, Netherlands

St. Antonius locatie Leidsche Rijn

Utrecht, Netherlands

Isala Klinieken

Zwolle, Netherlands

P.A. Herzen Oncological Inst. ; Oncology

Moscow, Russian Federation

First Pavlov State Medical University of St.Petersburg

Saint-Petersburg, Russian Federation

Oncology Institute of Vojvodina

Sremska Kamenica, Serbia

Institute of Oncology Ljubljana

Ljubljana, Slovenia

Hospital Universitario Son Espases

Palma De Mallorca, Spain

Ijsselland Ziekenhuis; Inwendige Geneeskunde

Capelle A/d IJssel, Netherlands

Hospital Erasme; Neurologie

Bruxelles, Belgium

Clinique Saint-Joseph

Liège, Belgium

Rigshospitalet, Onkologisk Klinik

København Ø, Denmark

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.